AGIO Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 4.93%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $912,905.28

Agios Pharmaceuticals Insider Trading History Chart

Agios Pharmaceuticals Share Price & Price History

^$27.40

▼ -1.9 (-6.48%)

As of 04/1/2025 05:00 PM ET

Days: 30 | 90 | 365

Agios Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
1/6/2025	Tsveta Milanova	Insider	Sell	2,804	$32.18	$90,232.72	18,906
12/11/2024	David Scadden	Director	Sell	200	$46.28	$9,256.00	15,483
9/26/2024	Cecilia Jones	CFO	Sell	2,542	$49.03	$124,634.26	20,158
8/8/2024	Brian Goff	CEO	Sell	11,091	$42.75	$474,140.25	78,792
4/10/2024	Jacqualyn A. Fouse	Director	Sell	7,791	$27.55	$214,642.05	137,396
3/5/2024	Brian Goff	CEO	Sell	4,156	$32.57	$135,360.92	53,780
3/5/2024	James William Burns	Insider	Sell	2,642	$32.57	$86,049.94	34,518
3/5/2024	Kaye I Foster-Cheek	Director	Sell	300	$32.21	$9,663.00	11,224
2/20/2024	Theodore James Jr. Washburn	Insider	Sell	504	$26.63	$13,421.52	2,741
2/14/2024	Sarah Gheuens	Insider	Sell	642	$25.14	$16,139.88	33,431
1/24/2024	Brian Goff	CEO	Sell	7,635	$21.64	$165,221.40	49,436
1/24/2024	Cecilia Jones	CFO	Sell	1,886	$21.64	$40,813.04	13,069
1/24/2024	Jacqualyn A. Fouse	Director	Sell	10,722	$21.64	$232,024.08	129,253
1/24/2024	James William Burns	Insider	Sell	1,708	$21.64	$36,961.12	30,378
1/9/2024	Brian Goff	CEO	Sell	12,066	$22.99	$277,397.34	40,053
1/9/2024	Jacqualyn A. Fouse	Director	Sell	8,391	$22.99	$192,909.09	116,075
1/9/2024	James William Burns	Insider	Sell	1,163	$22.99	$26,737.37	26,336
1/5/2024	Tsveta Milanova	Insider	Sell	2,902	$22.32	$64,772.64	9,404
9/28/2023	Cecilia Jones	CFO	Sell	2,179	$24.79	$54,017.41	9,575
8/17/2023	James William Burns	Insider	Sell	6,395	$26.28	$168,060.60	23,890
8/9/2023	Kaye I Foster-Cheek	Director	Sell	25,000	$25.96	$649,000.00	11,524
8/7/2023	Theodore James Jr. Washburn	Insider	Sell	2,918	$25.39	$74,088.02	2,741
8/1/2023	Theodore James Jr. Washburn	Insider	Sell	1,232	$26.26	$32,352.32	5,659
6/30/2023	Brian Goff	CEO	Sell	11,449	$28.36	$324,693.64	14,079
6/30/2023	Cecilia Jones	CFO	Sell	1,597	$28.36	$45,290.92	3,783
6/30/2023	Jacqualyn A. Fouse	Director	Sell	10,718	$28.36	$303,962.48	106,966
6/30/2023	James William Burns	Insider	Sell	1,707	$28.36	$48,410.52	30,285
4/3/2023	David P Schenkein	Director	Sell	16,363	$22.85	$373,894.55	117,879
3/27/2023	David P Schenkein	Director	Sell	20,000	$22.15	$443,000.00	117,879
3/13/2023	David P Schenkein	Director	Sell	20,000	$22.49	$449,800.00	117,879
3/3/2023	Theodore James Jr. Washburn	Insider	Sell	504	$24.29	$12,242.16	2,741
2/16/2023	Theodore James Jr. Washburn	Insider	Sell	233	$27.21	$6,339.93	2,668
2/13/2023	David P Schenkein	Director	Sell	20,000	$28.62	$572,400.00	117,879
1/30/2023	David P Schenkein	Director	Sell	20,000	$29.33	$586,600.00	117,879
1/17/2023	David P Schenkein	Director	Sell	20,000	$28.85	$577,000.00	117,879

See Full Table

SEC Filings (Institutional Ownership Changes) for Agios Pharmaceuticals (NASDAQ:AGIO)

Institutional Buying and Selling by Quarter

Agios Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
3/24/2025	Wellington Management Group LLP	25,489	$0.84M	0.0%	-13.4%	0.044%
3/18/2025	California State Teachers Retirement System	48,255	$1.59M	0.0%	-1.0%	0.084%
2/19/2025	GF Fund Management CO. LTD.	1,197	$39K	0.0%	N/A	0.002%
2/18/2025	Frazier Life Sciences Management L.P.	1,069,754	$35.15M	1.5%	+2.5%	1.876%
2/17/2025	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	122,835	$4.04M	0.0%	+8.5%	0.215%
2/17/2025	Voloridge Investment Management LLC	200,481	$6.59M	0.0%	+2.1%	0.352%
2/17/2025	Squarepoint Ops LLC	162,415	$5.34M	0.0%	N/A	0.285%
2/17/2025	Twinbeech Capital LP	141,073	$4.64M	0.1%	N/A	0.247%
2/17/2025	Two Sigma Advisers LP	22,200	$0.73M	0.0%	N/A	0.039%
2/17/2025	Two Sigma Investments LP	109,373	$3.59M	0.0%	N/A	0.192%
2/17/2025	Tidal Investments LLC	20,789	$0.68M	0.0%	-4.8%	0.036%
2/17/2025	Tema Etfs LLC	25,735	$0.85M	0.4%	N/A	0.045%
2/17/2025	Silvercrest Asset Management Group LLC	83,157	$2.73M	0.0%	+4.1%	0.146%
2/17/2025	Rafferty Asset Management LLC	70,313	$2.31M	0.0%	-21.4%	0.123%
2/17/2025	Polar Capital Holdings Plc	627,036	$20.60M	0.1%	-37.4%	1.099%
2/17/2025	ProShare Advisors LLC	18,619	$0.61M	0.0%	+32.6%	0.033%
2/17/2025	Paradigm Biocapital Advisors LP	276,439	$9.08M	0.3%	N/A	0.485%
2/17/2025	Patient Square Capital LP	121,732	$4M	1.5%	N/A	0.213%
2/17/2025	Nuveen Asset Management LLC	157,273	$5.17M	0.0%	-3.4%	0.276%
2/17/2025	OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC	43,330	$1.42M	0.1%	+5.5%	0.076%
2/17/2025	Orbimed Advisors LLC	26,700	$0.88M	0.0%	N/A	0.047%
2/17/2025	Millennium Management LLC	22,196	$0.73M	0.0%	-71.5%	0.039%
2/17/2025	Moore Capital Management LP	60,000	$1.97M	0.0%	-40.0%	0.105%
2/17/2025	Janus Henderson Group PLC	23,797	$0.78M	0.0%	-8.1%	0.042%
2/17/2025	Jefferies Financial Group Inc.	1,500,000	$49.29M	0.3%	N/A	2.618%
2/17/2025	Hudson Bay Capital Management LP	110,000	$3.62M	0.0%	+83.3%	0.193%
2/17/2025	Granahan Investment Management LLC	115,687	$3.80M	0.2%	-23.3%	0.203%
2/17/2025	Farallon Capital Management LLC	5,674,466	$186.46M	0.9%	+0.2%	9.950%
2/17/2025	D. E. Shaw & Co. Inc.	516,475	$16.97M	0.0%	-3.0%	0.906%
2/17/2025	Deutsche Bank AG	935,252	$30.73M	0.0%	+39.7%	1.640%
2/17/2025	Crestline Management LP	18,105	$0.60M	0.0%	N/A	0.032%
2/17/2025	Cutter Capital Management LP	301,623	$9.91M	4.1%	+61.6%	0.529%
2/17/2025	Casdin Capital LLC	250,000	$8.22M	0.5%	N/A	0.438%
2/17/2025	Brevan Howard Capital Management LP	47,326	$1.56M	0.0%	+341.2%	0.083%
2/17/2025	BVF Inc. IL	1,073,755	$35.28M	1.2%	-9.8%	1.883%
2/17/2025	Balyasny Asset Management L.P.	248,038	$8.15M	0.0%	N/A	0.435%
2/17/2025	Bellevue Group AG	3,515,150	$115.51M	2.2%	-5.9%	6.164%
2/17/2025	Bank of America Corp DE	404,902	$13.31M	0.0%	+21.6%	0.710%
2/17/2025	BNP Paribas Financial Markets	9,704	$0.32M	0.0%	-18.8%	0.017%
2/17/2025	Ameriprise Financial Inc.	39,262	$1.29M	0.0%	-46.5%	0.069%
2/17/2025	Algert Global LLC	12,240	$0.40M	0.0%	-67.2%	0.021%
2/17/2025	ArrowMark Colorado Holdings LLC	917,420	$30.15M	0.4%	+3.9%	1.609%
2/17/2025	AXA S.A.	175,377	$5.76M	0.0%	-26.5%	0.308%
2/14/2025	Gallagher Fiduciary Advisors LLC	11,110	$0.37M	0.1%	+7.6%	0.019%
2/14/2025	Caligan Partners LP	626,280	$20.58M	5.5%	+8.0%	1.098%
2/14/2025	Jane Street Group LLC	214,027	$7.03M	0.0%	+58.8%	0.375%
2/14/2025	PDT Partners LLC	8,485	$0.28M	0.0%	-85.0%	0.015%
2/14/2025	Northern Trust Corp	595,480	$19.57M	0.0%	+0.9%	1.044%
2/14/2025	The Manufacturers Life Insurance Company	122,094	$4.01M	0.0%	-14.9%	0.214%
2/14/2025	Tudor Investment Corp ET AL	28,553	$0.94M	0.0%	N/A	0.050%
2/14/2025	Boothbay Fund Management LLC	251,774	$8.27M	0.2%	+8.0%	0.441%
2/14/2025	Virtus ETF Advisers LLC	9,160	$0.30M	0.1%	+30.1%	0.016%
2/14/2025	Voya Investment Management LLC	33,007	$1.09M	0.0%	-48.2%	0.058%
2/14/2025	Adage Capital Partners GP L.L.C.	303,000	$9.96M	0.0%	N/A	0.531%
2/14/2025	Price T Rowe Associates Inc. MD	2,423,537	$79.64M	0.0%	-14.4%	4.250%
2/14/2025	Hsbc Holdings PLC	30,584	$1M	0.0%	+532.9%	0.054%
2/14/2025	Rock Springs Capital Management LP	471,086	$15.48M	0.6%	-32.6%	0.826%
2/14/2025	Tower Research Capital LLC TRC	10,286	$0.34M	0.0%	+236.6%	0.018%
2/14/2025	MetLife Investment Management LLC	34,579	$1.14M	0.0%	+5.9%	0.061%
2/14/2025	Dimensional Fund Advisors LP	1,329,065	$43.67M	0.0%	-14.9%	2.330%
2/14/2025	First Trust Advisors LP	97,259	$3.20M	0.0%	-12.3%	0.171%
2/13/2025	CANADA LIFE ASSURANCE Co	18,979	$0.62M	0.0%	-5.5%	0.033%
2/13/2025	Marshall Wace LLP	631,628	$20.76M	0.0%	-50.0%	1.108%
2/13/2025	Guggenheim Capital LLC	13,703	$0.45M	0.0%	N/A	0.024%
2/13/2025	XTX Topco Ltd	9,272	$0.31M	0.0%	+11.3%	0.016%
2/13/2025	Barclays PLC	121,753	$4M	0.0%	-42.7%	0.213%
2/13/2025	Summit Investment Advisors Inc.	5,913	$0.19M	0.2%	+7.1%	0.010%
2/13/2025	Sterling Capital Management LLC	1,781	$59K	0.0%	+818.0%	0.003%
2/13/2025	Kennedy Capital Management LLC	111,098	$3.65M	0.1%	+281.4%	0.195%
2/13/2025	CenterBook Partners LP	305,599	$10.04M	0.6%	+98.3%	0.536%
2/13/2025	Martingale Asset Management L P	15,520	$0.51M	0.0%	-56.0%	0.027%
2/13/2025	Capula Management Ltd	20,849	$0.69M	0.0%	N/A	0.037%
2/13/2025	Legal & General Group Plc	71,677	$2.36M	0.0%	-1.9%	0.126%
2/13/2025	Invesco Ltd.	83,515	$2.74M	0.0%	-29.8%	0.146%
2/13/2025	Federated Hermes Inc.	13,691	$0.45M	0.0%	+4.4%	0.024%
2/13/2025	Envestnet Asset Management Inc.	24,805	$0.82M	0.0%	+3.3%	0.043%
2/13/2025	Wells Fargo & Company MN	34,808	$1.14M	0.0%	-184.9%	0.061%
2/12/2025	Trexquant Investment LP	69,971	$2.30M	0.0%	+180.3%	0.123%
2/12/2025	Headlands Technologies LLC	26,736	$0.88M	0.1%	+94.5%	0.047%
2/12/2025	Geode Capital Management LLC	1,349,651	$44.36M	0.0%	-0.6%	2.367%
2/12/2025	Franklin Resources Inc.	66,461	$2.18M	0.0%	+83.0%	0.117%
2/12/2025	Alliancebernstein L.P.	61,500	$2.02M	0.0%	+1.2%	0.108%
2/12/2025	Wellington Management Group LLP	25,489	$0.84M	0.0%	-13.4%	0.045%
2/12/2025	Pictet Asset Management Holding SA	354,455	$11.65M	0.0%	-11.6%	0.622%
2/12/2025	Norges Bank	145,092	$4.77M	0.0%	N/A	0.254%
2/12/2025	Loomis Sayles & Co. L P	417,208	$13.71M	1.5%	-31.9%	0.732%
2/12/2025	NEOS Investment Management LLC	25,735	$0.85M	0.0%	+10.9%	0.045%
2/12/2025	JPMorgan Chase & Co.	1,015,360	$33.37M	0.0%	-40.7%	1.780%
2/12/2025	Artisan Partners Limited Partnership	499,134	$16.40M	0.0%	+27.4%	0.875%
2/11/2025	EntryPoint Capital LLC	7,804	$0.26M	0.1%	N/A	0.014%
2/11/2025	Prudential Financial Inc.	104,922	$3.45M	0.0%	+111.9%	0.184%
2/11/2025	Corebridge Financial Inc.	28,098	$0.92M	0.0%	-7.0%	0.049%
2/11/2025	Vanguard Group Inc.	5,631,321	$185.05M	0.0%	+1.5%	9.874%
2/11/2025	Fox Run Management L.L.C.	23,839	$0.78M	0.1%	N/A	0.042%
2/11/2025	KLP Kapitalforvaltning AS	10,000	$0.33M	0.0%	N/A	0.018%
2/11/2025	Sei Investments Co.	13,601	$0.45M	0.0%	-41.3%	0.024%
2/11/2025	American Century Companies Inc.	104,837	$3.45M	0.0%	-8.2%	0.184%
2/11/2025	Quantbot Technologies LP	2,863	$94K	0.0%	-12.8%	0.005%
2/11/2025	Magnetar Financial LLC	6,501	$0.21M	0.0%	N/A	0.011%
2/11/2025	Teacher Retirement System of Texas	15,176	$0.50M	0.0%	+18.4%	0.027%

Data available starting January 2016

See Full Table

Agios Pharmaceuticals, Inc., a biopharmaceutical company, discovers and develops medicines in the field of cellular metabolism in the United States. Its lead product includes PYRUKYND (mitapivat), an activator of wild-type and mutant pyruvate kinase (PK), enzymes for the treatment of hemolytic anemias. The company develops AG-946, a PK activator for treating lower-risk myelodysplastic syndrome and hemolytic anemias; and AG-181, a phenylalanine hydroxylase stabilizer for the treatment of phenylketonuria. Its preclinical product is siRNA for the treatment of polycythemia vera, a rare blood disorder. Agios Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Cambridge, Massachusetts.

Today's Range

Now: $27.40

$26.66

$29.35

50 Day Range

MA: $33.11

$29.30

$35.54

52 Week Range

Now: $27.40

$26.66

$62.58

Volume

936,690 shs

Average Volume

702,355 shs

Market Capitalization

$1.57 billion

P/E Ratio

2.42

Dividend Yield

N/A

Beta

0.9

Who are the company insiders with the largest holdings of Agios Pharmaceuticals?: Agios Pharmaceuticals' top insider shareholders include:
Jacqualyn A Fouse (Director)
David P Schenkein (Director)
Brian Goff (CEO)
James William Burns (Insider)
Sarah Gheuens (Insider)
Cecilia Jones (CFO)
Tsveta Milanova (Insider)
David Scadden (Director)
Kaye I Foster-Cheek (Director)
Theodore James Jr Washburn (Insider)
Learn More about top insider investors at Agios Pharmaceuticals.
Who are the major institutional investors of Agios Pharmaceuticals?: Agios Pharmaceuticals' top institutional shareholders include:
Farallon Capital Management LLC — 9.95%
Vanguard Group Inc. — 9.87%
Bellevue Group AG — 6.16%
Price T Rowe Associates Inc. MD — 4.25%
Erste Asset Management GmbH — 3.52%
Jefferies Financial Group Inc. — 2.62%
Learn More about top institutional investors of Agios Pharmaceuticals stock.
Which major investors are selling Agios Pharmaceuticals stock?: Within the previous quarter, AGIO stock was sold by these institutional investors:
JPMorgan Chase & Co.
Marshall Wace LLP
Price T Rowe Associates Inc. MD
Polar Capital Holdings Plc
Dimensional Fund Advisors LP
Rock Springs Capital Management LP
Bellevue Group AG
Loomis Sayles & Co. L P
In the previous year, company insiders that have sold Agios Pharmaceuticals company stock include:
Jacqualyn A Fouse (Director)
David P Schenkein (Director)
Brian Goff (CEO)
James William Burns (Insider)
Sarah Gheuens (Insider)
Learn More investors selling Agios Pharmaceuticals stock.
Which major investors are buying Agios Pharmaceuticals stock?: In the last quarter, AGIO stock was acquired by institutional investors including:
Jefferies Financial Group Inc.
Adage Capital Partners GP L.L.C.
Paradigm Biocapital Advisors LP
Deutsche Bank AG
Casdin Capital LLC
Balyasny Asset Management L.P.
Squarepoint Ops LLC
CenterBook Partners LP